PPIs, especially lansoprazole, esomeprazole, rabeprazole, and omeprazole, have been demonstrated to inhibit hOAT3, which, in turn, decreases the metabolism of methotrexate and can lead to the worsening of side effects, including gastric ulcers [6]. The gene discussed is SLC22A8; the disease is gastric ulcer.